Oral Etoposide for Relapsed or Refractory Ewing Sarcoma in Adolescent and Adult Patients
Oral Etoposide for Relapsed or Refractory Ewing Sarcoma in Adolescent and Adult Patients
About this item
Full title
Author / Creator
Publisher
Egypt: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Egypt: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Prognosis remains poor for patients with relapsed or refractory Ewing sarcoma, with limited treatment options after first‐line therapy. Oral etoposide has efficacy in the paediatric setting; however, data are limited in adults. A retrospective analysis was conducted on 33 patients with relapsed or refractory Ewing sarcoma who completed at least one...
Alternative Titles
Full title
Oral Etoposide for Relapsed or Refractory Ewing Sarcoma in Adolescent and Adult Patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3148499751
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3148499751
Other Identifiers
ISSN
1357-714X
E-ISSN
1369-1643
DOI
10.1155/sarc/8247342
